Evidence map›Paper›PMID 30558267›Full record

ArticleMolecules (Basel, Switzerland)2018

RNA⁻Protein Interactions Prevent Long RNA Duplex Formation: Implications for the Design of RNA-Based Therapeutics.

Eckart Bindewald, Lisheng Dai, Wojciech K Kasprzak, Taejin Kim, Shuo Gu, Bruce A Shapiro

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Eckart BindewaldRNA Biology Laboratory, Basic Science Program, Frederick National Laboratory for Cancer Research supported by the National Cancer Institute, Frederick, MD 21702, USA. eckart@mail.nih.gov.
Lisheng DaiRNA Biology Laboratory, National Cancer Institute, Frederick, MD 21702, USA. lisheng.dai@nih.gov.
Wojciech K KasprzakRNA Biology Laboratory, Basic Science Program, Frederick National Laboratory for Cancer Research supported by the National Cancer Institute, Frederick, MD 21702, USA. kasprzaw@mail.nih.gov.
Taejin KimRNA Biology Laboratory, National Cancer Institute, Frederick, MD 21702, USA. taejin.kim@nih.gov.
Shuo GuRNA Biology Laboratory, National Cancer Institute, Frederick, MD 21702, USA. shuo.gu@nih.gov.ORCID 0000-0002-7924-5363
Bruce A ShapiroRNA Biology Laboratory, National Cancer Institute, Frederick, MD 21702, USA. shapirbr@mail.nih.gov.
National Cancer Institute · USFrederick National Laboratory for Cancer Research · US

Funding

Uncover the mechanisms regulating the biogenesis and decay of miRNAs in cancerZIABC011566 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI GU, SHUO · 2014 to 2025
$16.3M
6 · The paper itself

Abstract

Cells frequently simultaneously express RNAs and cognate antisense transcripts without necessarily leading to the formation of RNA duplexes. Here, we present a novel transcriptome-wide experimental approach to ascertain the presence of accessible double-stranded RNA structures based on sequencing of RNA fragments longer than 18 nucleotides that were not degraded by single-strand cutting nucleases. We applied this approach to four different cell lines with respect to three different treatments (native cell lysate, removal of proteins, and removal of ribosomal RNA and proteins). We found that long accessible RNA duplexes were largely absent in native cell lysates, while the number of RNA duplexes was dramatically higher when proteins were removed. The majority of RNA duplexes involved ribosomal transcripts. The duplex formation between different non-ribosomal transcripts appears to be largely of a stochastic nature. These results suggest that cells are-via RNA-binding proteins-mostly devoid of long RNA duplexes, leading to low "noise" in the molecular patterns that are utilized by the innate immune system. These findings have implications for the design of RNA interference (RNAi)-based therapeutics by imposing structural constraints on designed RNA complexes that are intended to have specific properties with respect to Dicer cleavage and target gene downregulation.

Indexed as

Base SequenceEndoribonucleasesHEK293 CellsHumansProtein BindingRibosomesRNA-Binding ProteinsRNA, Double-StrandedRNA, RibosomalSolventsEndoribonucleasesRNA-Binding ProteinsRNA, Double-StrandedRNA, RibosomalSolventsDicerhelixinteractionribosomal RNA (rRNA)RNA-bindingRNA-binding protein (RBP)RNA–RNA

Identifiers

PMID30558267
PMCPMC6321275
OpenAlexW2905516393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.